• 00:00 1.
    index 1
  • 00:15 2.
    METTL3 mRNA was higher in gastric cancer
  • 03:02 3.
    Knockdown METTL3 inhibited the tumor proliferation
  • 03:55 4.
    Knockdown METTL3 inhibited the tumor proliferation
  • 03:57 5.
    Knockdown METTL3 inhibited the tumor proliferation
  • 04:16 6.
    Knockdown METTL3 inhibited the tumor proliferation
  • 05:50 7.
    Knockdown METTL3 inhibited the tumor proliferation
  • 06:21 8.
    Knockdown METTL3 inhibited the tumor proliferation
  • 09:22 9.
    METTL3 might have m6A-independent oncogenic functions
  • 20:07 10.
    METTL3 might have m6A-independent oncogenic functions
  • 23:14 11.
    METTL3 might have m6A-independent oncogenic functions
  • 26:47 12.
    METTL3 mainly located in cytoplasm in GC cells
  • 28:31 13.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 30:08 14.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 30:10 15.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 30:12 16.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 32:20 17.
    METTL3 regulated the translation of transcripts without m6A modification
  • 37:55 18.
    METTL3 regulated the translation of transcripts without m6A modification
  • 37:58 19.
    METTL3 regulated the translation of transcripts without m6A modification
  • 38:01 20.
    METTL3 regulated the translation of transcripts without m6A modification
  • 38:23 21.
    METTL3 promotes mRNA translation in an m6Aindependent manner
  • 42:43 22.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 48:35 23.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 48:41 24.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 48:42 25.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 50:31 26.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 53:41 27.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 56:48 28.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 57:49 29.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:00:14 30.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:01:14 31.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:01:15 32.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:01:32 33.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:02:09 34.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:02:54 35.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:04:17 36.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:05:58 37.
    Slide 32
  • 1:06:54 38.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:06:54 39.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:06:54 40.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:06:55 41.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:06:56 42.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:06:56 43.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:06:57 44.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:06:58 45.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:06:59 46.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 1:07:33 47.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:07:33 48.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:07:33 49.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:07:34 50.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:07:34 51.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:07:35 52.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:07:35 53.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:07:35 54.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:07:36 55.
    Slide 32
  • 1:07:36 56.
    Slide 33
  • 1:07:37 57.
    Slide 32
  • 1:10:49 58.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:10:49 59.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:10:49 60.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:10:49 61.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 1:10:50 62.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:10:50 63.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:10:50 64.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:10:51 65.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 1:10:51 66.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 1:10:52 67.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 1:10:52 68.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 1:10:52 69.
    METTL3 promotes mRNA translation in an m6Aindependent manner
  • 1:10:53 70.
    METTL3 regulated the translation of transcripts without m6A modification
  • 1:10:54 71.
    METTL3 regulated the translation of transcripts without m6A modification
  • 1:10:55 72.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 1:10:56 73.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 1:10:56 74.
    METTL3 mainly located in cytoplasm in GC cells
  • 1:10:57 75.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 索引
  • 筆記
  • 討論
  • 全螢幕
20221206 lab meeting_家銘
長度: 1:13:45, 瀏覽: 170, 最近修訂: 2022-12-05
附件:
    上一篇 下一篇
    • 00:00 1.
      index 1
    • 00:15 2.
      METTL3 mRNA was higher in gastric cancer
    • 03:02 3.
      Knockdown METTL3 inhibited the tumor proliferation
    • 03:55 4.
      Knockdown METTL3 inhibited the tumor proliferation
    • 03:57 5.
      Knockdown METTL3 inhibited the tumor proliferation
    • 04:16 6.
      Knockdown METTL3 inhibited the tumor proliferation
    • 05:50 7.
      Knockdown METTL3 inhibited the tumor proliferation
    • 06:21 8.
      Knockdown METTL3 inhibited the tumor proliferation
    • 09:22 9.
      METTL3 might have m6A-independent oncogenic functions
    • 20:07 10.
      METTL3 might have m6A-independent oncogenic functions
    • 23:14 11.
      METTL3 might have m6A-independent oncogenic functions
    • 26:47 12.
      METTL3 mainly located in cytoplasm in GC cells
    • 28:31 13.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 30:08 14.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 30:10 15.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 30:12 16.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 32:20 17.
      METTL3 regulated the translation of transcripts without m6A modification
    • 37:55 18.
      METTL3 regulated the translation of transcripts without m6A modification
    • 37:58 19.
      METTL3 regulated the translation of transcripts without m6A modification
    • 38:01 20.
      METTL3 regulated the translation of transcripts without m6A modification
    • 38:23 21.
      METTL3 promotes mRNA translation in an m6Aindependent manner
    • 42:43 22.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 48:35 23.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 48:41 24.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 48:42 25.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 50:31 26.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 53:41 27.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 56:48 28.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 57:49 29.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:00:14 30.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:01:14 31.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:01:15 32.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:01:32 33.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:02:09 34.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:02:54 35.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:04:17 36.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:05:58 37.
      Slide 32
    • 1:06:54 38.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:06:54 39.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:06:54 40.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:06:55 41.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:06:56 42.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:06:56 43.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:06:57 44.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:06:58 45.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:06:59 46.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 1:07:33 47.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:07:33 48.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:07:33 49.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:07:34 50.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:07:34 51.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:07:35 52.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:07:35 53.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:07:35 54.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:07:36 55.
      Slide 32
    • 1:07:36 56.
      Slide 33
    • 1:07:37 57.
      Slide 32
    • 1:10:49 58.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:10:49 59.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:10:49 60.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:10:49 61.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 1:10:50 62.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:10:50 63.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:10:50 64.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:10:51 65.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 1:10:51 66.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 1:10:52 67.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 1:10:52 68.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 1:10:52 69.
      METTL3 promotes mRNA translation in an m6Aindependent manner
    • 1:10:53 70.
      METTL3 regulated the translation of transcripts without m6A modification
    • 1:10:54 71.
      METTL3 regulated the translation of transcripts without m6A modification
    • 1:10:55 72.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 1:10:56 73.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 1:10:56 74.
      METTL3 mainly located in cytoplasm in GC cells
    • 1:10:57 75.
      Cytoplasmic METTL3 enables its oncogenic activity
    位置
    1. 知識庫
    2. ...
    3. 2022
    資料夾名稱
    2022
    發表人
    林俐妤
    單位
    賴亮全教授
    建立
    2022-12-05 11:14:10
    最近修訂
    2022-12-05 11:43:24
    長度
    1:13:45

    臺北市仁愛路一段1號10樓1009室

    R1009 10F No1 Sec1 Ren-Ai Rd, Taipei 100233, Taiwan.

    E-mail: llai@ntu.edu.tw

    Tel: 886-2-2312-3456 # 288241

    Lab: 886-2-2393-8235